Risk communication to patients from a European perspective
- At: Basel (Switzerland) (2008)
- Type: Presentation
- By: BAHRI, Priya (EMEA, London, United Kingdom)
Although the authorities regulate medicines, they should never lose sight of the patient. It is the patient who should benefit from pharmacological treatment and in whose favour any risks associated with the prescribed medicine should be minimised. A central process for risk minimisation is communication between all parties at various levels... The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.